CLINICAL_TRIALS
trial_result
· 2021-12-09
Clinical Trial Update: MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria [Phase 2]
Summary
Phase 2 trial update for MMV390048 in Plasmodium vivax and Plasmodium falciparum malaria; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 2 | Status: TERMINATED | Results posted: 2021-12-09